Key result
Regulatory warnings urge cautious prescribing of cholesterol-lowering drugs due to increased adverse reaction risks.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
There are reasons to be cautious about prescribing all cholesterol lowering drugs.1 The West Midlands Centre for Adverse Drug Reactions, which produces the Adverse Drug Reaction Bulletin , has recently issued a warning via the Food and Drug Administration (FDA) concerning a potentially increased …
No takes yet. Share an insight, caveat, or question.
M. Struthers (2008) studied this question. Cholesterol-lowering drugs warrant cautious prescribing following regulatory warnings regarding a potentially increased risk of adverse drug reactions.
Synapse has enriched 10 related papers. Consider them for comparative context: